ARTICLE | Company News
Merck, Paratek antibiotic deal
March 10, 2006 2:39 AM UTC
Paratek (Boston, Mass.) granted MRK exclusive worldwide rights to develop and commercialize PTK 0796, an aminomethylcycline (AMC) antibiotic. An IV and an oral formulation of PTK 0796 are in Phase I t...